|
| SHORT COMMUNICATION | | | Year : 2008 | Volume : 70 | Issue : 3 | Page : 393-395 | | | Simultaneous spectrophotometric estimation of paracetamol and metoclopramide hydrochloride in solid dosage form | | | SJ Wadher, PR Pathankar, Manisha Puranik, RO Ganjiwale, PG Yeole
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha- 442 001, India
| Date of Submission | 09-Apr-2007 | | Date of Decision | 20-Dec-2007 | | Date of Acceptance | 19-Jun-2008 | Correspondence Address:
S J Wadher
Department of Pharmaceutical Chemistry, Institute of Pharmaceutical Education and Research, Borgaon (Meghe), Wardha- 442 001
India
  | 7 |
DOI: 10.4103/0250-474X.43014 PMID: 20046757 | |  Abstract | | | Two simple, accurate, rapid and economical spectrophotometric methods have been developed for the simultaneous determination of paracetamol and metoclopramide hydrochloride from tablet dosage form. The first method developed employs formation and solving simultaneous equations using 248.6 nm and 275.6 nm as two wavelengths for formation of equations. Second method is absorbance ratio in which wavelengths selected were 265.6 nm as isoabsorptive point and 275.6 nm as lmax of paracetamol. Both the drugs and their mixtures obey Beer-Lamberts law at selected wavelengths at given concentration range. The methods have been validated statistically and by recovery studies. The results of analysis have been validated statistically and by recovery studies.
Keywords: Paracetamol, metoclopramide, simultaneous spectrophotometric, isoabsorptive methods
How to cite this article:
Wadher S J, Pathankar P R, Puranik M, Ganjiwale R O, Yeole P G. Simultaneous spectrophotometric estimation of paracetamol and metoclopramide hydrochloride in solid dosage form. Indian J Pharm Sci 2008;70:393-5 |
How to cite this URL:
Wadher S J, Pathankar P R, Puranik M, Ganjiwale R O, Yeole P G. Simultaneous spectrophotometric estimation of paracetamol and metoclopramide hydrochloride in solid dosage form. Indian J Pharm Sci [serial online] 2008 [cited 2014 Mar 5];70:393-5. Available from: http://www.ijpsonline.com/text.asp?2008/70/3/393/43014 |
Paracetamol is chemically N-(4-hydroxyphenyl) acetamide. It is used mainly as antipyretic [1] . Metoclopramide is 4-amino-5-chloro N-(2-diethylaminoethyl)-2-methoxy benzamide. It finds its use as antiemetic [2] . Literature survey reveals that gas chromatography [3] , HPLC [4] , titrimetric [5] and densitometric [6] methods are available for the determination of paracetamol and spectrphotometric [7],[8] , HPLC [9] and 1 H NMR spectroscopic [10] methods for the determination of metoclopramide. The review of literature revealed that no method is yet reported for the simultaneous determination of both the drugs in combined dosage form. This paper describes two simple, rapid, accurate, reproducible and economical methods for the simultaneous determination of metoclopramide and paracetamol from tablet formulation.
A Shimadzu UV/Vis spectrophotometer-2401 with UVPC software and with 10 mm matched quartz cell was used for experiments. All the chemicals and solvents used during project work were of analytical grade. All the solutions were filtered using Whatman filter paper no. 41. Simultaneous equation method was employed as the method I. Pure drug sample of metoclopramide and paracetamol were dissolved separately in methanol so as to give several dilutions of standard in the concentration range 0-30 μg/ml of metoclopramide and paracetamol. All dilutions were scanned in the wavelength range of 400-200 nm. [Figure 1] represents the overlain spectra of both the drugs. Two wavelengths selected for the formation of simultaneous equation are 248.6 nm and 275.6 nm ('λ max of paracetamol and metoclopramide) and following equations were used Cx= 179.76 A2 -514.12 A 1 /445902.57 (1) and Cy= 165 A 1 -925.14 A 2 /445902.57 (2), where, A 1 and A 2 are absorbance of sample solution at 248.6 nm and 275.6 nm, respectively, Cx and Cy are concentration (in g/100 ml) of paracetamol and metoclopramide, respectively in sample solution. Molar absorptivities determined for metoclopramide at 248.6 nm and 275.6 nm are 179.96 and 514.12, respectively, and molar absorptivities determined for paracetamol at 248.6 nm and 275.6 nm are 165 and 925.14, respectively.
For the estimation of drugs from the commercial formulation, twenty tablets of brand Paramet (Wallace Pharmaceutical, Goa) containing 5 mg of metoclopramide (MET) and 500 mg of paracetamol (PAR). Twenty tablets were weighed accurately and average weight per tablet was calculated. Tablets were ground to a fine powder. A quantity equivalent to 100 mg of PAR was transferred to a 100 ml volumetric flask. MET present in this tablet powder was 1 mg, which could not be found out accurately due to low absorbance; hence to increase the accuracy, accurately weighed 99 mg pure drug sample of MET was transferred to the same volumetric flask. The powder was dissolved in 50 ml methanol with vigorous shaking and volume was made to mark with methanol. The solution was further diluted to get final concentration of 10 μg/ml of PAR (or MET). The absorbance of the solution was measured at 248.6 nm and 275.6 nm and concentration of the two drugs was calculated using Eqns. 1 and 2. The results of tablet formulation are shown in [Table 1].
In isoabsorptive point was employed as method II, in which the absorbance was measured at two wavelengths, one being the isoabsorptive point of the two components and other being the wavelength of maximum absorption of one of the two components. From the overlain spectra of two drugs absorbances were measured at selected wavelength i.e. 265.6 nm isoabsorptive point and 275.6 nm, 'λmax of MET [Figure 1].
The absorbance and absorptivity values at the particular wavelengths were calculated and substituted in the following equation; to obtain the concentration Cx= (Qm-Qy)×A/(Qx-Qy)×ax 1 (3) and Cy= A/ax 1 -Cx (4); where, Cx and Cy are concentration in g/100 ml of PAR and MET, respectively. A is the absorbance of mixture at isoabsorptive point; ax 1 is the absorbtivity of PAR at isoabsorptive point. Qx was obtained by using the equation, (absorptivity of PAR at 275.6 nm)/ (absorptivity of MET at 265.6 nm); Qy was obtained from (absorptivity of MET at 275.6 nm)/ (absorptivity of PAR at 265.6 nm). Qm from (absorbance of sample at 275.6 nm/absorbance of sample at 265.6 nm)
Tablet solution was prepared in methanol as described earlier and was further diluted to obtain the solution having concentration 10 μg/ml of PAR (or MET). This solution was then analyzed to obtain the spectra and absorbance value at 275.6 nm and 265.6 nm were noted. These values were then equated in above mentioned Eqns. 3 and 4 and the concentration of each drug was calculated and results of tablet formulation are shown in [Table 1].
To study the accuracy, reproducibility and precision of the above proposed methods, recovery studies were carried out by addition of standard drug to pre-analyzed sample. Results of recovery studies were found to be satisfactory and reported in [Table 2]. The value of standard deviation was satisfactorily low and recovery was close to 100% include the reproducibility and accuracy of both the methods.
The first method employing simultaneous equation is a very simple method and can be employed for routine analysis of these two drugs in combined dosage form using simple instrumentation. Once the molar absorptions are determined, very little time will be required for routine analysis, as it would only require determination of absorbance of sample at the two selected wavelengths and few simple calculations.
The second method employed the graphic absorbance ratio at two selected wavelength, once the absorbance is determined. The reported methods were found to be accurate, simple and rapid. Hence it can be employed for routine analysis of both drugs in quality control laboratories.
| Acknowledgement | |  |
Authors are grateful to Modi-MundiPharma Pvt. Ltd, for gift sample.
| References | | |
| 1. | Indian Pharmacopoeia, Govt. of India, Ministry of Health and Family Welfare, Vol. 2, Delhi: Publication by Controller of Publication; 1996. p. 484, 554.  | | 2. | British Pharmacopoeia, 1993, Vol. 1, International ed. Published on the Recommendation of the Medicines Commissions Pursuant to Medicines Act; 1968, 1993. p. 429,483. | | 3. | Becheracci C, Runchi FM, Segre G. Gas chromatographic method for emergency determination of paracetamol in plasma. Farmaco Ed Prat 1981;36:312. | | 4. | Ebel S, Liedtake R, Misster B. Determination of paracetamol in blood sample by HPLC. Archive Der Phamazie 1980;313:324. | | 5. | Adikwu MU. Titrimetric assay of paracetamol using DMSO. Pharmacy World J 1991;8:84. | | 6. | Concheiro A, Vila JL, Labres M. Densitometric method for determination of paracetamol in urine. Ciene Ind Farm 1982;1:38. | | 7. | Amine AS, Ragab GH. Spectrophotometric methods for the determination of antiemetic drugs in bulk and in pharmaceutical preparation. Anal Sci 2003;19(5):747. | | 8. | Patel SA, Patel CN, Patel MM. Visible spectrophotometric methods for the estimation of metoclopramide in tablets. Indian J Pharm Sci 2006;68:397. | | 9. | Bryson SM, Megoven EM, Gilbert LM. Evaluation of HPLC technique for metoclopramide analysis. J Clin Hosp Pharm 1984;V9:263. | | 10. | Hanna GM, Lau Cam CA. [1] H NMR spectrophotometric assay method for metoclopramide in tablets and injection. Drug Develop Ind Pharm 1991;V17(7):975. |
[Figure 1]
[Table 1], [Table 2] | |
| This article has been cited by | | 1 | Charge-transfer interactions of metoclopramide nausea drug against six kind of p-acceptors: Spectral and thermal discussions | | | Abeer A. El-Habeeb,Foziah A. Al-Saif,Moamen S. Refat | | Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2014; 123: 455 | | [Pubmed] | | | 2 | Formulation Development and Evaluation of Hybrid Nanocarrier for Cancer Therapy: Taguchi Orthogonal Array Based Design | | | Rakesh K. Tekade,Mahavir B. Chougule | | BioMed Research International. 2013; 2013: 1 | | [Pubmed] | | | 3 | Studying the compatibility of a metoclopramide-HCl–paracetamol mixture via IHCMC and establishing a validated RP-HPLC method for its determination in tablets | | | Amira M. Hegazy,Raimar Loebenberg,Nagiba Y. Hassan,Fadia H. Metwally,Mohammad Abdel-Kawy | | Analytical Methods. 2013; 5(15): 3714 | | [Pubmed] | | | 4 | STAT6 siRNA Matrix-Loaded Gelatin Nanocarriers: Formulation, Characterization, and Ex Vivo Proof of Concept Using Adenocarcinoma Cells | | | Susanne R. Youngren,Rakesh K. Tekade,Brianne Gustilo,Peter R. Hoffmann,Mahavir B. Chougule | | BioMed Research International. 2013; 2013: 1 | | [Pubmed] | | | 5 | Voltammetric and amperometric determination of metoclopramide on boron-doped diamond film electrode | | | Hana Dejmkova,Candan Dag,Jiri Barek,Jiri Zima | | Central European Journal of Chemistry. 2012; 10(4): 1310 | | [Pubmed] | | | 6 | Application of potassium permanganate to spectrophotometric assay of metoclopramide hydrochloride in pharmaceuticals | | | O. Zenita Devi, K. Basavaiah, K. B. Vinay | | Journal of Applied Spectroscopy. 2012; | | [VIEW] | | | 7 | Sensitive spectrophotometric determination of metoclopramide hydrochloride in dosage forms and spiked human urine using vanillin | | | O. Zenita Devi,K. Basavaiah,K.B. Vinay,H.D. Revanasiddappa | | Arabian Journal of Chemistry. 2011; | | [Pubmed] | |
| | | | |   | | | | | |
| Article Access Statistics | | | Viewed | 5574 | | | Printed | 68 | | | Emailed | 3 | | | PDF Downloaded | 444 | | | Comments | [Add] | | | Cited by others | 7 | | | | 
|
